On the basis of our previous identified linkage regions for nicotine dependence (ND), we selected seven and four single nucleotide polymorphisms (SNPs) in the b-arrestins 1 (ARRB1) and 2 (ARRB2), respectively, to determine the associations of the two genes with ND in a total of 2037 subjects from 602 nuclear families of European American (EA) and African American (AA) origin. ND was assessed by Smoking Quantity (SQ), the Heaviness of Smoking Index (HSI) and the Fagerströ m Test for ND (FTND) score. Individual SNP analysis indicated that SNPs rs472112 within ARRB1 and rs4790694 within ARRB2 in the EA sample was significantly associated with HSI and FTND score, and the association of rs4790694 for ARRB2 remained significant after correction for multiple testing. Haplotype analysis revealed that haplotype C-G-C-G-G-T within ARRB1 at a frequency of 20%, formed by SNPs rs528833, rs1320709, rs480174, rs5786130, rs611908 and rs472112, was positively associated with HSI and FTND in EAs. We also found a haplotype within ARRB2, C-C-A-T at a frequency of 10.7%, formed by SNPs rs3786047, rs4522461, rs1045280 and rs4790694, that showed a significant positive association with HSI and FTND in the EA sample. No significant associations for either individual SNPs or major haplotype of both ARRB1 and ARRB2 were found in the AA sample. Further, the strength of these associations increased after removing the SQ component from HSI and FTND scores in both the EA and AA samples, suggesting that ARRB1 and ARRB2 play an important role in biological processes involved in the regulation of smoking urgency (that is time to smoke first cigarette). In summary, our results provide the first evidence of a significant association for ARRB1 and ARRB2 variants with ND in an EA sample.
Introduction
Tobacco use is a leading preventable cause of death in the United States, with one in every five deaths attributable to smoking. 1 Nicotine is believed to be the primary addictive component of cigarette smoke. Nicotine dependence (ND) is a complex quantitative trait that is influenced by both genetic and environmental factors. 2 A number of linkage and association studies have identified susceptibility genes for ND; 3, 4 however, few association studies of candidate genes and/or linkage analyses for susceptibility loci have been replicated in independent samples. 3, 5 Previously, we identified several chromosomal regions that are likely to harbor susceptibility loci for ND in the Framingham Heart Study (FSH) and Mid-South Tobacco Family (MSTF) samples, including one region on chromosome 11q13 and one on chromosome 17p13, 3, [6] [7] [8] where the two genes of interest, b-arrestins 1 and 2 (ARRB1 and ARRB2), are located, 9, 10 respectively. b-arrestins are key negative regulators and scaffolds for G-protein-coupled receptor (GPCR) signaling, one of the most fundamental cellular signal transduction processes. They promote an uncoupling of G-protein-dependent receptor signaling (receptor desensitization) via interaction with phosphorylated GPCRs. 11, 12 Both ARRB1 and ARRB2 act as molecular scaffolds that recruit signaling molecules such as kinases and phosphatases to the activated receptors; the formation of b-arrestin-based signaling complexes facilitates the activation and/or inhibition of these signaling molecules. 13 The genes ARRB1 and ARRB2 span approximately 23.9 and 11 kb, and consist of 16 and 14 exons, respectively. Both genes are widely expressed in multiple tissues and organs, with especially high expression levels in brain tissues. Double knockout of ARRB1 and ARRB2 is lethal to mice, while knockout of either ARRB1 or ARRB2 is not, [14] [15] [16] suggesting the presence of some overlapping functions. Oakley et al. 17 delineated GPCRs into two major classes: class A receptors preferentially bind ARRB2, whereas class B receptors have equal affinity for both b-arrestins.
Opioid receptors belong to the GPCR superfamily. Considerable evidence has shown the opioid receptors play a central role in the development of drug abuse via the disinhibition of ventral tegmental area (VTA) dopaminergic neurons. [18] [19] [20] [21] Previous reports indicated that the reinforcing properties of nicotine are strongly diminished in mice lacking the m-opioid receptor, 22 and acute nicotine administration increased the expression of m-opioid receptors in the VTA. 23 b-arrestins have been proven to be important regulators of signal transduction mediated by opioid receptors through promotion of receptor desensitization and internalization. [24] [25] [26] Additionally, b-arrestins are known to be involved in the mitogen-activated protein kinases (MAPK) pathway, which is connected to GPCR signaling by the seven transmembrane receptor or b 2 -adrenergic receptors. MAPK has been implicated in mediating the reinforcing effects of drugs of abuse and the neural plasticity associated with various addictive drugs. [27] [28] [29] [30] However, no published studies exist examining the direct association between b-arrestins and drug addiction. Terwilliger et al. 31 reported that chronic morphine administration increases b-arrestin levels in the rat locus coeruleus.
As multifunctional adaptor of scaffold proteins in the opioid receptor and MAPK signaling processes, together with the location of ARRB1 and ARRB2 on two-linked chromosomal regions to ND, we were motivated to determine whether the ARRB1 and ARRB2 are associated with ND. In this study, we performed an association analysis of single and multiple SNPs within ARRB1 and ARRB2 in 602 nuclear families of European American (EA) or African American (AA) origin and found that both ARRB1 and ARRB2 are associated with ND in EA smokers. The degree of ND for each smoker was ascertained by the three measures most commonly used in published studies: Smoking Quantity (SQ), the Heaviness of Smoking Index (HSI; 0-6 scale) and the Fagerströ m Test for ND score (FTND; 0-10 scale). 32 Our primary reasons for examining all three ND measures were: (a) the current lack of consensus regarding the best approach to assess ND as a phenotype and (b) to permit maximum cross-reference with previous studies of ND. The FTND has been accepted as a standard in both clinical and research settings, although recent evidence suggests that ND is a broader and more complex construct than previously considered. 33 Thus, while it is premature to endorse other measures that have received interesting but limited support, we believe it is prudent to examine our genetic findings with respect to the three aforementioned measures. Given the presence of overlap in the content of the three ND measures, fairly robust correlations exist among them (AAs: r = 0.89-0.97; EAs: r = 0.91-0.97). A detailed description of the demographic and clinical characteristics of the participants is available in previous publications from this group. [34] [35] [36] DNA extraction, SNP selection and SNP genotyping DNA was extracted from peripheral blood samples of each participant using a DNA Maxi kit purchased from Qiagen Inc. (Valencia, CA, USA). On the basis of high heterozygosity (minor allele frequency X0.15) and uniform coverage of the gene, seven and four SNPs within ARRB1 and ARRB2 were selected from the NCBI database (http://www.ncbi.nlm.nih.gov/; Build 124), respectively. Table 1 provides detailed information on the SNPs used in this study.
Materials and methods

Participants and smoking phenotypes
All SNPs were genotyped using the TaqMan assay in a 384-well microplate format (Applied Biosystems Inc., Foster City, CA, USA). Briefly, 15 ng of DNA was amplified in a total volume of 7 ml containing an MGB probe and 2.5 ml of TaqMan universal PCR master mix. The amplification conditions were 2 min at 501C and 10 min at 951C followed by 40 cycles of 951C for 25 s and 601C for 1 min. Allelic discrimination analysis was performed on the ABI Prism 7900HT Sequence Detection System (ABI, Foster City, CA, USA). To ensure the quality of the genotyping, consistent results were required for eight control samples added to each 384-well reaction plate.
Statistical and association analyses
Pair-wise linkage disequilibrium (LD) between all SNPs was assessed using the Haploview (v. 3.2) program 37 with the option of determining haplotype blocks according to the criteria defined by Gabriel et al. 38 The PedCheck program 39 was used to identify Associations between single SNPs and the three ND measures were determined using the PBAT program's (v. 2.0) generalized estimating equations procedure, 40 which permits correction for covariates. Associations between each ND measure and haplotypes from multiple SNP combinations were examined using the FBAT program (v. 1.5.5) with the option of computing P-values of the Z-statistic based on Monte-Carlo sampling under the null distribution of no linkage and no association. 41 Three genetic models (additive, dominant and recessive) were tested for both individual and multi-locus SNPs. Gender and age were entered as covariates, as they have been shown to influence ND. 2, [42] [43] [44] The three ND measures (SQ, HSI and FTND) were analyzed individually. All associations found to be significant were corrected for multiple testing according to the SNP spectral decomposition (SNPSpD) approach 45 for individual SNP analyses. As the SNPSpD approach is inappropriate for examining combinations in haplotypebased association analysis, we employed a Bonferroni correction, dividing the significance level by the number of major haplotypes (frequency > 5.0%). In consideration of high correlations between the three ND measures and among the results under different genetic models, we chose not to correct for testing of the three highly correlated ND measures or genetic models to avoid being over-conservative. This is because there is no generally accepted methodology capable of handling the problem of highly correlated multiple testing. (However, if one wishes to correct for multiple testing for the three highly related genetic models and/or phenotypes, a justified P-value can be obtained by dividing the corrected P-value after correction for major haplotypes given in the note #1 of Tables 4-7 by 6, i.e., two independent tests for the three genetic models multiply by three ND measures.)
Results
Association analysis of individual SNPs with ND w 2 -Tests revealed significant differences in haplotype frequencies across the EA and AA samples. Thus, we performed association analysis of individual SNPs for ARRB1 and ARRB2 using PBAT-GEE program separately for each ethnic group. Significant associations were identified in the EA sample for SNP rs472112 within ARRB1 for HSI under the recessive model (P = 0.0202) and FTND under both the dominant and recessive models (P = 0.0178). SNP rs5786130 was also associated with FTND score under the recessive model (P = 0.0399) in the EA sample. However, these associations were no longer significant after correction for multiple testing (Table 2) . Association analysis of individual SNPs within ARRB2 for the EA sample showed a significant association for SNP rs4790694 with HSI score (minimum P = 0.012; Table 3 ), and with FTND score (minimum P = 0.0147; Table 3 ); these remained significant after correction for multiple testing. No significant association was detected for any individual SNP within ARRB1 and ARRB2 in the AA sample.
The pair-wise D-values for the seven SNPs within ARRB1 and four SNPs within ARRB2 were calculated separately using Haploview program. 37 According to the criteria for block definition from Gabriel et al., 38 two haplotype blocks of approximately 17 and 21 kb within ARRB1 were found in the EA sample. One encompassed rs2279130, rs528833 and rs1320709 Figure 1 ), and the other included rs480174, rs5786130 and rs611908 (D 0 > 0.80). These two blocks were not present in the AA sample. For ARRB2, a single haplotype block of 7 kb consisting of rs3786047, rs4522461 and rs1045280 was identified in the EA sample (D 0 > 0.89, Figure 2) ; again, no block was found for AAs. These results indicate that different LD patterns exist among the SNPs within ARRB1 and ARRB2 between the AA and EA samples.
Haplotype analysis of multiple SNPs with ND
Using the FBAT program, haplotype-based association analysis was performed for all possible combinations of three or more SNPs (including consecutive and non-consecutive SNPs) within ARRB1 and ARRB2. Similar to the single SNP analysis, we performed separate haplotype analyses for the EA and AA samples. In the EA group, we found a major haplotype C-G-C-G-G-T within ARRB1 at a frequency of 20.0%, formed by SNPs rs528833, rs1320709, rs480174, rs5786130, rs611908 and rs472112, which showed a significant positive association with the adjusted HSI score (Z = 2.92, P = 0.0035, number of families = 58) under the dominant model, and FTND (Z = 2.91 and 3.36, P = 0.0037 and 0.0008, number of families = 60 and 58) under the additive and dominant models. These associations remained significant after Bonferroni correction for testing of six major haplotypes. In contrast, in the AA sample, we found a major haplotype C-G-T-G-G-T with a frequency of 7.2%, formed by the same SNP combination, which was inversely associated with HSI and FTND (Z = À2.06, P = 0.039, and Z = À2.03; P = 0.043; number of families = 59) under the dominant model. However, these associations were no longer significant after Bonferroni correction (Table 4) .
Within ARRB2, the haplotype C-C-A-T of rs3786047-rs4522461-rs1045280-rs4790694 with a frequency of 10.7% was shown to be positively associated with HSI (Z = 2.59, P = 0.0097, number of families = 28) and FTND (Z = 2.43, P = 0.0152, number of families = 28) under the additive model for the EA sample. These associations remained significant after Bonferroni correction for three major haplotypes. In the AA sample, haplotype T-A-G-G with a frequency of 4.3% formed by the same four SNPs revealed a significant inverse association with all three adjusted ND measures (Z = À2.47 to À2.23; P = 0.0136-0.0261; number of families = 26.2) under both the additive and dominant models. After Bonferroni correction, however, these associations were no longer statistically significant (Table 5 ). Tables 2-6 , we found that ARRB1 and ARRB2 were associated with HSI and FTND, but not with SQ. Given both HSI and FTND measures include SQ as a component of their measure, we reasoned that their associations should improve after removing the SQ influence. Thus, we re-examined our findings listed for SNPs (Tables 2 and 3) and haplotypes  (Tables 4 and 5 ). Individual SNP analysis showed that in the EA sample, SNPs rs472112 within ARRB1 and rs4790694 within ARRB2 became more strongly associated with both HSI-SQ (P = 0.0121-0.0130 and 0.0012-0.0020; Table 6 ) and FTND-SQ (P = 0.0132-0.0160 and 0.0049-0.0078; Table 6 ) than with the original HSI and FTND scores, respectively. This association trend appears to be true for SNP rs472112 within ARRB1 in the AA sample.
Association analysis of individual and multiple SNPs with HSI-SQ and FTND-SQ As shown in
Similarly, in the EA sample, we found that the haplotype C-G-C-G-G-T within ARRB1 became more strongly associated with both HSI-SQ and FTND-SQ (Z = 2.95-3.46; P = 0.0005-0.0032; Table 7 ). Also, the haplotype C-C-A-T within ARRB2 showed greater Table 7 ) than with HSI and FTND scores.
As a final check, we examined the association of the FTND with both items from the HSI removed. As is evident on Tables 6 and 7 , this score (FTND-HSI) never performed superior to the FTND-SQ or HSI-SQ, and almost always produced much weaker association results.
Discussion
On the basis of location of ARRB1 and ARRB2 on the genomic regions linked to ND 3,6-8 and their biological The adjusted P-values at the 0.05 and 0.01 significance levels after Bonferroni correction for six major haplotypes in the EA sample are 0.0083 and 0.0017, and for five major haplotypes in the AA sample are 0.01 and 0.002, respectively. Given that the three genetic models and three ND measures are so highly related to each other, we feel that it is too conservative to apply a Bonferroni correction to these comparisons. However, if one wishes to correct for them, the adjusted P-value at the 0.05 significance level becomes 0.0014 for the EA sample and 0.0017 for the AA sample. This approach can be applied to Tables  5-7 as well. Superscripts indicate the genetic models used in the analysis: a, additive; d, dominant; r, recessive model. The ND measures used in the analysis were corrected for age and gender in each ethnic sample. [24] [25] [26] 46 and the extensive evidence that opioid receptors and MAPK cascades are involved in drug addiction, [18] [19] [20] [21] [22] [27] [28] [29] [30] ARRB1 and ARRB2 were considered plausible candidates for ND. To test this hypothesis, in this study, seven SNPs within ARRB1 and four SNPs within ARRB2, as well as haplotypes of various combinations of these SNPs were examined for association with ND in 602 nuclear families of either AA or EA origin. Three commonly used ND measures (SQ, HSI and FTND) were analyzed to facilitate cross-study replication by others.
In the EA sample, one SNP (rs4790694) within ARRB2 was proved significantly associated with HSI and FTND after correction for multiple testing. Further, we found one major haplotype each from ARRB1 and ARRB2, which showed significant positive associations with HSI and FTND after Bonferroni correction in the EA sample. No significant associations for individual SNP of either ARRB1 or ARRB2 were found in the AA sample. Significant associations for the haplotypes C-G-T-G-G-T within ARRB1 and T-A-G-G within ARRB2 with ND were detected in the AA sample; however, they became non-significant after correction for multiple testing. It is unlikely that the sample size was a factor in this cross-racial pattern of findings, as the AA sample consisted of 1366 subjects from 402 families, whereas the EA group included only 602 subjects from 200 families. Moreover, these association results are supported by the LD pattern that SNPs rs2279130-rs528833-rs1320709 and rs480174-rs5786130-rs611908 are located within a haplotype block of ARRB1 in the EA sample (Figure 1 ), but are not present in the AA sample. Similarly, within ARRB2, three SNPs from the significant four SNP combinations are within a haplotype block in the EA sample (Figure 2 ). These findings indicate haplotype specificity exists across ethnicity, and associations are most likely due to the ethnic differences in distributions of SNP and haplotype frequencies. These results are consistent with previous reports. [47] [48] [49] However, we must temper our conclusions given the presence of some borderline findings for AAs, suggesting the need for replication.
Another interesting and unexpected finding was that the allelic variants or haplotypes of both ARRB1 and ARRB2 were associated with HSI and FTND, but not SQ. Subsequently, stronger relationships were noted for the HSI and FTND once the SQ item was removed. As such, the HSI-SQ is based on a single item, 'How soon after you wake up do you smoke your first cigarette?' The modified FTND-SQ score also includes this item, plus four others representing preference for morning smoking and addressing smoking persistence. [50] [51] [52] Collectively, these items appear to address an individual's need to restore or maintain a minimally acceptable concentration of nicotine in the body, that is smoking urgency. 53 Subsequent follow-up analyses suggest it is the dimensions tapped by the smoking urgency that are most strongly related to the variants of b-arrestins, with those addressed by the remaining FTND items playing a similar, but weaker role. Taken together, our results strongly indicate that b-arrestins 1 and 2 may play important roles in the biological pathways involved in the regulation of smoking urgency.
In summary, our family-based association analysis revealed a haplotype within ARRB1 and both a SNP and a haplotype within ARRB2 showed significant associations with ND in an EA sample. On the basis of the findings from this study and the known functions of opioid receptors and MAPK signaling processes, we conclude that ARRB1 and ARRB2 may represent an important candidate in the etiology of ND, especially in the aspect related to smoking urgency. Given the presence of marginal association of ARRB1 and ARRB2 with ND in the AA smokers, more replication is thus warranted in independent samples. Table 7 Z and permutation P-values for the association of significant haplotypes (Tables 4 and 5 
